tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BCYC Stock Latest News

Bicycle Therapeutics price target lowered to $25 from $32 at RBC Capital
The FlyBicycle Therapeutics price target lowered to $25 from $32 at RBC Capital
11d ago
BCYC
Bicycle Therapeutics Approves Proposals at Annual Meeting
PremiumCompany Announcements
Bicycle Therapeutics Approves Proposals at Annual Meeting
1M ago
8K
BCYC
Bicycle Therapeutics price target raised to $17 from $15 at Morgan Stanley
PremiumThe Fly
Bicycle Therapeutics price target raised to $17 from $15 at Morgan Stanley
3M ago
BCYC
Bicycle Therapeutics: Strong Pipeline Progress and Strategic Expansion Support Buy Rating
PremiumRatings
Bicycle Therapeutics: Strong Pipeline Progress and Strategic Expansion Support Buy Rating
3M ago
BCYC
Bicycle Therapeutics price target lowered to $14 from $17 at B. Riley
PremiumThe Fly
Bicycle Therapeutics price target lowered to $14 from $17 at B. Riley
3M ago
BCYC
Bicycle Therapeutics price target lowered to $22 from $26 at Citizens JMP
PremiumThe FlyBicycle Therapeutics price target lowered to $22 from $26 at Citizens JMP
3M ago
BCYC
Bicycle Therapeutics Reports Q1 2025 Progress and Financials
Premium
Company Announcements
Bicycle Therapeutics Reports Q1 2025 Progress and Financials
3M ago
BCYC
Bicycle Therapeutics price target lowered to $15 from $40 at Barclays
Premium
The Fly
Bicycle Therapeutics price target lowered to $15 from $40 at Barclays
3M ago
BCYC
Bicycle Therapeutics: Promising Advancements and Strong Financial Position Justify Buy Rating
PremiumRatings
Bicycle Therapeutics: Promising Advancements and Strong Financial Position Justify Buy Rating
3M ago
BCYC
Promising Developments in Bicycle Therapeutics’ Pipeline Bolster Buy Rating
PremiumRatings
Promising Developments in Bicycle Therapeutics’ Pipeline Bolster Buy Rating
3M ago
BCYC
Bicycle Therapeutics reports Q1 EPS (88c), consensus (81c)
PremiumThe Fly
Bicycle Therapeutics reports Q1 EPS (88c), consensus (81c)
3M ago
BCYC
Promising Imaging Data and Future Trials Support Buy Rating for Bicycle Therapeutics
PremiumRatings
Promising Imaging Data and Future Trials Support Buy Rating for Bicycle Therapeutics
3M ago
BCYC
Bicycle Therapeutics Reveals Promising Imaging Data at AACR
PremiumCompany AnnouncementsBicycle Therapeutics Reveals Promising Imaging Data at AACR
3M ago
8K
BCYC
Bicycle Therapeutics: Buy Rating Backed by Promising Clinical Developments and Strategic Positioning
Premium
Ratings
Bicycle Therapeutics: Buy Rating Backed by Promising Clinical Developments and Strategic Positioning
4M ago
BCYC
Bicycle Therapeutics Announces Key Leadership Changes
Premium
Company Announcements
Bicycle Therapeutics Announces Key Leadership Changes
4M ago
8K
BCYC
Bicycle names Pierre Legault chairman, Eric Westin chief medical officer
PremiumThe Fly
Bicycle names Pierre Legault chairman, Eric Westin chief medical officer
4M ago
BCYC
Promising Upside for Bicycle Therapeutics: Buy Rating Backed by Positive Clinical Data and Market Potential for ZP Treatment
PremiumRatings
Promising Upside for Bicycle Therapeutics: Buy Rating Backed by Positive Clinical Data and Market Potential for ZP Treatment
5M ago
BCYC
Bicycle Therapeutics: Promising Pipeline Progress and Expansion Opportunities Drive Buy Rating
PremiumRatings
Bicycle Therapeutics: Promising Pipeline Progress and Expansion Opportunities Drive Buy Rating
5M ago
BCYC
Bicycle Therapeutics Reports 2024 Progress and Financial Results
PremiumCompany Announcements
Bicycle Therapeutics Reports 2024 Progress and Financial Results
5M ago
BCYC
Promising Developments and Strong Financial Position Drive Positive Outlook for Bicycle Therapeutics
PremiumRatingsPromising Developments and Strong Financial Position Drive Positive Outlook for Bicycle Therapeutics
5M ago
BCYC
Bicycle Therapeutics: Undervalued Stock with Promising Pipeline and Innovative Platform
Premium
Ratings
Bicycle Therapeutics: Undervalued Stock with Promising Pipeline and Innovative Platform
5M ago
BCYC
Promising Outlook for Bicycle Therapeutics: Strong Clinical Progress and Financial Health Justify Buy Rating
Premium
Ratings
Promising Outlook for Bicycle Therapeutics: Strong Clinical Progress and Financial Health Justify Buy Rating
5M ago
BCYC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >